(SMED) |
| 0 (0%) 08-02 22:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.19 |
| Resistance 1: | 10.50 |
| Pivot price: | 10.12 |
| Support 1: | 9.39 |
| Support 2: | 7.81 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.820 |
| Book Value | 0.000 |
| PEG Ratio | 0.97 |
| Gross Profit | 21.826 |
| Profit Margin (%) | -5.78 |
| Operating Margin (%) | -7.20 |
| Return on Assets (ttm) | -4.3 |
| Return on Equity (ttm) | -9.8 |
Company news
Thu, 04 Jun 2026
USPTO Updates Its SMED Guidance — and Signals That It’s Working - IPWatchdog.com
Wed, 27 May 2026
Andreas Smed - Transfermarkt
Wed, 27 May 2026
Smed’s blockchain-optional MMOFPS Reaper Actual has delayed again, this time to May 29 - Massively Overpowered
Thu, 14 May 2026
TrustNordisk Adds Niels Arden Oplev’s ’Shadow & Light,’ Starring Esben Smed (EXCLUSIVE) - Variety
Tue, 12 May 2026
USPTO Issues Updated Best Practices Memorandum on Subject Matter Eligibility Declarations (SMEDs) Under Rule 132 - Crowell & Moring LLP
Tue, 05 May 2026
USPTO Updates SMED Guidance, Encourages Demonstrating Technological Improvement - The National Law Review
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
